News

FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
STAT6d
FDA commissioner evades questions on Covid shot, calls CDC panel a ‘kangaroo court’
In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...
FDA grants limited approval to new Covid vaccine from Moderna
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
FDA’s plan to limit covid vaccines worries some who won’t be eligible
If coronavirus vaccines are restricted to seniors and those at high risk, parents of young children and relatives of ...
MPR2d
FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike
The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...
FDA changing COVID vaccine guidelines. An NC doctor says who can still get it
The FDA will no longer recommend annual COVID vaccinations for healthy people younger than 65. A North Carolina doctor says ...
Moderna's new lower-dose COVID-19 vaccine approved by FDA
The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...
ConsumerAffairs5d
Moderna wins FDA approval for its new COVID-19 vaccine
FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...
Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals
Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved ...
The Cardiology Advisor2d
FDA Chief: COVID Vaccine in Pregnancy Should Be Personal Choice
Dr. Marty Makary, head of the U.S. Food and Drug Administration (FDA), said Wednesday that the decision should be made between a pregnant woman and her doctor. “The data on the COVID vaccine booster ...
KSL7d
FDA approves Moderna's next-generation COVID vaccine for adults 65 and older
The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...